As part of our expert series on the state of the industry, OneMedRadio spoke with Glysure CEO Chris Jones to discuss this recent news and learn about this unique technology. Jones also discussed trends in the industry affecting company growth and investment strategy, including reimbursement issues, evolving exit strategy, and the move away from normative medicine.
San Diego-based Freedom Meditech, Inc., a privately-held medical device company focused on commercialization of ophthalmic technologies for the detection of disease and management of patient health, last week announced it had secured a $2MM line of credit from Silicon Valley Bank.
The significant differences between Echo Therapeutics’ Symphony system and the competition is the needle-free transdermal biosensor, clinical trials in the hospital setting and biosensor life.
Medtronic announced at its annual investor meeting that it has acquired substantially all glucose monitoring technology from Danish company PreciSense.
Copyright © 2024 | WordPress Theme by MH Themes